• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • Contact

2018 TVM Capital Life Science Autumn Conference

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • Contact

autumn-conference-2018Now in its 7th year, our annual TVM Capital Life Science Autumn Conference 2018 was held on Monday, September 17th in Montreal.

Our invitation-only conference was again attended by approx. 200 international participants from Asia, the United States and Europe who joined us to network with senior decision makers from biotech and pharmaceutical companies as well as venture capital groups and discuss latest trends in our industry as well as share expertise and experience.

Thanks to attendants  and above all to our sponsors who contribute a lot to make this event happen.

Please click here to visit our photogallery of this year’s event!

For any requests please contact risman (at) tvm-capital.com.

Agenda

12.30amWelcome Address
Luc Marengere, Managing Partner, TVM Capital Life Science
12.45pm – 1:30pmStrategic View of Oncology Therapeutic Development
Jullian Jones, Sr. Director, Oncology Search & Evaluation, Eli Lilly and Company

Introduction by Vanessa Grant, Norton Rose Fulbright
1:30pm – 2:15pmThe Emerging Renaissance of Radiotherapy
Steffen Schuster, CEO, Isotope Technologies Munich (ITM)

Introduction by Stefan Fischer, CFO and General Partner, TVM Capital Life Scienc
2:15pm – 3:15pmMolecular Diagnostics and Pharmaceutical Product Development – How to Work Together to Maximise Value for all Stakeholders – Panel Discussion
Andrew Schade, Distinguished Medical Fellow, Eli Lilly and Company
Jean-Pascal Viola, SVP Corporate Business Development, QIAGEN
Richard Watts, VP Business Development/Companion Diagnostics, QIAGEN
Greg Zdechlik, COO Diagnostic Development/Commercialization, Eli Lilly and Company

Moderators: Hubert Birner/Daniel Parera
Introductions by Kristina Bieker-Brady, McDermott Will & Emery
3:15pm – 3:45pmCoffee Break
3:45pm – 4:30pmAlternative Strategies to Reach The Public Markets – Panel Discussion
Harry Palmin, COO & CFO Acer Therapeutics
David Schechner, Managing Director, R.W. Baird
John Sonnier, Managing Director, William Blair
David Strupp, Managing Director & Head of Healthcare Investment Banking, Ladenburg Thalmann & Co.

Moderator: Luc Marengere
4:30pm – 5:15pmTransforming Knee Care: Better Outcomes, better Value for all Stakeholders
Michele Laflamme, CEO, Emovi

Introduction by Didier Leconte, Fonds de solidarité FTQ
5:15pm – 5:30pmWrap up, Outlook and Acknowledgements
Hubert Birner, Managing Partner, TVM Capital Life Science
5:30pmEvening Reception at Hotel Sofitel Salon Paloma Picasso

Download Agenda (PDF)

Platinum Sponsor
norton-rose-fulbright Fonds de Solidarite Lilly McDermott Will and Emery
Gold Sponsors
aird & berlis Banque Nationale Biavalorem Ernst & Young foley hoag RBC

2018 TVM Capital Life Science Autumn Conference

Date:
September 17, 2018
Venue:
Hotel Sofitel, Salon Pablo Picasso 1155 Sherbrooke West, Montreal, Quebec H3A 2N3, Canada

  • in

Copyright © 2021 · TVM Capital Life Science Venture Capital · Privacy Policy · Contact